Articles tagged with “pharma-strategy”

Eli Lilly $3.8B Vaccine Acquisitions: Infectious Disease R&D

Examine Eli Lilly's $3.8B acquisition of three biotechs to build an infectious disease vaccine pipeline targeting shingles, EBV, and resistant bacteria.

35 min read

5/12/2026

eli lilly vaccine acquisitions infectious disease antimicrobial resistance shingles vaccine ebv vaccine pharma strategy biopharma pipeline

Pfizer Metsera Acquisition and GLP-1 Obesity Drug Market

Analyze Pfizer's $10B acquisition of Metsera and the evolving GLP-1 obesity drug market. Learn about competing pipelines, clinical data, and pharma strategy.

50 min read

5/2/2026

glp-1 agonists pfizer metsera acquisition obesity drugs pharmaceutical pipelines novo nordisk eli lilly pharma strategy weight loss medications

Patent Cliff Strategy: Role of Competitive Intelligence Software

Learn how pharma firms use competitive intelligence software to mitigate patent cliff risks. Updated April 2026 with the Humira/CVS Caremark biosimilar shift, Stelara LOE, and AI-native CI platforms.

35 min read

1/9/2026

competitive intelligence patent cliff loss of exclusivity pharma strategy ci software biosimilar competition drug patent expiration lifecycle management

KOL Mapping: A Pharma Playbook with Methods & Templates

Learn the complete KOL/HCP mapping process for pharma. This playbook covers data-driven methods for KOL identification, segmentation, and network analysis.

40 min read

11/11/2025

kol mapping hcp mapping medical affairs kol identification digital opinion leader pharma strategy kol engagement network analysis